{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:44:49Z","timestamp":1786635889151,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0253-7613.62399","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T02:13:15Z","timestamp":1271902395000},"page":"12","source":"Crossref","is-referenced-by-count":18,"title":["Loratadine versus levocetirizine in chronic idiopathic urticaria: A comparative study of efficacy and safety"],"prefix":"10.4103","volume":"42","author":[{"given":"Rituparna","family":"Maiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Anuradha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jyothirmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Mujeebuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Anuradha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.62399-1","first-page":"708","volume-title":"Management and diagnostic guidelines for urticaria and angio-oedema","author":"Grattan","year":"2001","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0253-7613.62399-2","first-page":"469","volume-title":"Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled, parallel, multicenter study","author":"Kapp","year":"2006","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0253-7613.62399-3","first-page":"533","volume-title":"Levocetirizine in the treatment of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0253-7613.62399-4","first-page":"196","volume-title":"Urticaria: Current opinions about etiology, diagnosis and therapy","author":"Zuberbier","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0253-7613.62399-5","unstructured":"Bruttman G. Comparative effects of Loratadine and Terfenadine in the treatment of chronic idiopathic urticaria. 7 th World Congress of Dermatology 1987,West Berlin."},{"key":"key-10.4103\/0253-7613.62399-6","first-page":"617","volume-title":"Loratadine: A reappraisal of its pharmacological properties and therapeutic use in allergic disorders","author":"Haria","year":"1994","journal-title":"Drugs"},{"key":"key-10.4103\/0253-7613.62399-7","first-page":"12","volume-title":"A multicentric trial of Loratadine and cetirizine chronic urticaria","author":"Thomas","year":"1998","journal-title":"Indian J Dermatol Venerol Leprol"},{"key":"key-10.4103\/0253-7613.62399-8","first-page":"23","volume-title":"Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria","author":"Garg","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0253-7613.62399-9","first-page":"1270","volume-title":"Cellular adhesion molecules in chronic urticaria: Modulation of serum levels occurs during Levocetirizine treatment","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0253-7613.62399-10","first-page":"2711","volume-title":"Levocetirizine: An update","author":"Walsh","year":"2006","journal-title":"Curr Med Chem"},{"key":"key-10.4103\/0253-7613.62399-11","first-page":"191","volume-title":"Levocetirizine in patients with chronic idiopathic urticaria: Results of a multicenter clinical practice study","author":"Pfaar","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.62399-12","first-page":"1073","volume-title":"A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions","author":"Wu","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"key-10.4103\/0253-7613.62399-13","first-page":"399","volume-title":"Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans","author":"Molimard","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"key-10.4103\/0253-7613.62399-14","first-page":"985","volume-title":"Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin","author":"Clough","year":"2001","journal-title":"Allergy"},{"key":"key-10.4103\/0253-7613.62399-15","first-page":"973","volume-title":"Levocetirizine: A review of its use in the management of allergic rhinitis and skin allergies","author":"Hair","year":"2006","journal-title":"Drugs"},{"key":"key-10.4103\/0253-7613.62399-16","first-page":"241","volume-title":"A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo","author":"Popov","year":"2006","journal-title":"Inflamm Res"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:51:25Z","timestamp":1786632685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.62399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"alternative-id":["62399"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.62399","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}